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ABSTRACT
In Escherichia coli, proteins GidA and MnmE are
involved in the addition of the carboxymethylamino-
methyl (cmnm) group onto uridine 34 (U34) of
tRNAs decoding two-family box triplets. However,
their precise role in the modification reaction
remains undetermined. Here, we show that GidA is
an FAD-binding protein and that mutagenesis of
the N-terminal dinucleotide-binding motif of GidA,
impairs capability of this protein to bind FAD and
modify tRNA, resulting in defective cell growth.
Thus, GidA may catalyse an FAD-dependent reac-
tion that is required for production of cmnmU34.
We also show that GidA and MnmE have identical
cell location and that both proteins physically
interact. Gel filtration and native PAGE experiments
indicate that GidA, like MnmE, dimerizes and
that GidA and MnmE directly assemble in an
a2b2 heterotetrameric complex. Interestingly, high-
performance liquid chromatography (HPLC) anal-
ysis shows that identical levels of the same
undermodified form of U34 are present in tRNA
hydrolysates from loss-of-function gidA and mnmE
mutants. Moreover, these mutants exhibit similar
phenotypic traits. Altogether, these results do not
support previous proposals that activity of MnmE
precedes that of GidA; rather, our data suggest
that MnmE and GidA form a functional complex in
which both proteins are interdependent.
INTRODUCTION
GidA-like proteins are widely distributed in nature. They are
conserved among Bacteria and Eukarya and have been
classiﬁed into two groups, based on the size of the protein
(1). One group includes proteins of about 600 amino acid
residues (GidAL), whereas the other comprises proteins of
approximately 450 residues (GidAS) that are truncated at
the C-terminal end compared to the larger ones. Alignment
of both the large and small forms of GidA revealed a
conserved, dinucleotide-binding motif at the N-terminus.
In fact, Myxococcus xanthus GidAS was shown to bind
FAD (1). Thus, it was suggested that GidA proteins either
catalyse oxidation–reduction reactions or act as sensors for
the redox state of the cell (1).
Recently, it has been shown that proteins GidAS corre-
spond to a novel class of bacterial site-speciﬁc tRNA
methyltransferases (tRNA:m
5U-54 Mtases), and they have
been renamed TrmFO (2). These enzymes catalyse the
site-speciﬁc formation of 5-methyluridine in position
54 (m
5U54) of tRNA using N
5, N
10-methylenetetrahydrofo-
late (CH2H4folate) as a source of one-carbon unit and a
combination of coenzymes NAD(P)H/FAD as reductant.
Therefore, they differ from TrmA enzymes, which also catal-
yse methylation of U54 but using S-adenosylmethionine as
the methyl donor. Curiously, the folate-dependent TrmFO
proteins and S-AdoMet-dependent TrmA/Trm2p enzymes
appear to have mutually exclusive phylogenetic distributions.
Thus, the Bacteria Bacillus subtilis, Aquifex aeolicus and
Thermotoga maritima lack TrmA but posses TrmFO.
Phylogenetic analyses also support that paralogous TrmFO
and GidAL(hereafter designated GidA) proteins are two
distinct families of proteins that probably evolved from a
common ancestor but acquired different, non-overlapping
cellular functions during evolution (2).
GidA was ﬁrst described in Escherichia coli, where
TrmFO is absent (note that methylation of U54 in E.coli
relies on TrmA). It was shown that disruption of gidA in
E.coli affects cell division, but only when cells are grown
on glucose (3). More recent data support that gidA is allelic
with trmF (also called mnmG), a gene involved in tRNA
modiﬁcation (4,5). According to this, GidA controls together
*To whom correspondence should be addressed. Tel: +34 963289680; Fax: +34 963289701; Email: armengod@cipf.es
Present address:
Lucı ´a Yim, Instituto de Higiene, Facultad de Medicina, Universidad de la Repu ´blica, Avda. Alfredo Navarro 3051, 11600 Montevideo, Uruguay
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
  2006 The Author(s).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
5892–5905 Nucleic Acids Research, 2006, Vol. 34, No. 20 Published online 24 October 2006
doi:10.1093/nar/gkl752with MnmE the addition of the carboxymethylaminomethyl
(cmnm) group in position 5 of the U34 of tRNAs that read
codons ending with A or G, in the mixed codon family
boxes, i.e. tRNA
Lys(UUU), tRNA
Glu(UUC), tRNA
Gln(UUG),
tRNA
Leu(UAA) and tRNA
Arg(UCU) but the precise role
of both proteins in the reaction modiﬁcation is hitherto
unknown (4–10). In tRNA
Lys(UUU) and tRNA
Glu(UUC)
(see Figure 1), MnmC transforms the cmnm
5 group into the
ﬁnal 5-methylaminomethyl (mnm
5) modiﬁcation, meanwhile
MnmA, together with IscS and proteins TusA-E, carries out
thiolation in the 2-position of the wobble uridine (6,11–13).
Modiﬁcations in the 2- and 5-positions occur independently
of each other; thus, thiolation may precede or follow the
synthesis of the side chain at position 5. When selenium
is available in the growth medium, sulfur at position 2
may be replaced by selenium in a reaction that is dependent
on SelD and YbbB (14). It should be noticed that non-
thiolated derivatives are present in tRNA
Leu(UAA) and
tRNA
Arg(UCU), (which contain mainly cmnm
5 and mnm
5,
respectively), whereas tRNA
Gln(UUG) contains mainly
cmnm
5s
2 (15). Moreover, it has been recently found that
tRNA
Gly(UCC) contains mainly mnm
5 (16), which suggests
that this tRNA is also a substrate for MnmE and GidA. Modi-
ﬁcation at position 5 mediated by GidA and MnmE appears
crucial for appropriate decoding of mRNA (4,16–20).
GidA and mnmE mutations are pleiotropic, affecting
diverse phenotypic traits. This may result from a translational
control exerted by GidA and MnmE throughout modiﬁcation
of speciﬁc tRNAs. Thus, GidA has been reported to be a
global regulator in the plant pathogen Pseudomonas syringae
since, mutations in gidA affects antibiotic production, swarm-
ing, presence of ﬂuorescent pigment, and virulence (21).
In the human pathogen Aeromonas hydrophila, disruption
of gidA reduces hemolytic and cytotoxic activity associated
with enterotoxin Act (22). Since this effect was shown to
be due to modulation of the act translation by GidA, it
was concluded that GidA regulates the most-potent virulence
factor of A.hydrophila, Act (22).
On the other hand, E.coli mnmE has been involved in
oxidation of certain heterocyclic substrates, such as thiophene
and furan (23), and resistance to acidic pH (24). Moreover,
loss-of-function mnmE mutations are lethal in combination
with mutations in some other genes involved in the mRNA
decoding process [(7,8,10) M. Villarroya, L. Yim and M.-E.
Armengod, in preparation]. In this respect, gidA mutations
have also been reported to be incompatible with mutations
disabling the normal decoding capability of certain tRNAs
(25). In addition, gidA and mnmE have been shown to be
essential in some human pathogens, such as Staphylococcus
aureus and Helicobacter pylori (26,27), supporting the notion
that tRNA modiﬁcation by MnmE and GidA is crucial for
survival of these species.
Interestingly, proteins GidA and MnmE are conserved
between Bacteria and Eukarya. MTO1 and MSS1/GTPBP3
were found to be the respective homologues of the gidA
and mnmE genes in both yeast and human (28–31). In
yeast, the protein products of MTO1 and MSS1 localize in
mitochondria, and their mutants are associated with respira-
tory defects (28,29,32). Also in yeast, it has been recently
reported that mitochondrial tRNA
Lys molecules isolated
from MTO1 and MSS1 deletion strains contain s
2U instead
of the cmnm
5s
2U found in the wild-type tRNA
Lys molecules;
this indicates that MTO1 and MSS1 genes are both involved
in the biosynthesis of the 5-carboxy-methylaminomethyl
group of cmnm
5s
2 of mitochondrial tRNA
Lys (32). Moreover,
the human cDNAs of GTPBP3 and MTO1 are able to
complement yeast MSS1 and MTO1 mutants, respectively
(30,31). Therefore, the function of GidA and MnmE seems
to be evolutionarily conserved.
The general purpose of this work was to gain further
insights into the GidA cellular function by studying its
location, self-assembly capability, interaction with MnmE
and relationships of its putative FAD-binding motif with
tRNA modiﬁcation and cell viability.
MATERIALS AND METHODS
Bacterial strains, phages, plasmids and
DNA manipulations
E.coli strains and plasmids used in this study are listed in
Table 1, unless speciﬁed otherwise. Genetic techniques for
the construction of strains were performed as described pre-
viously (33). For DNA manipulations, standard procedures
Figure 1. Modification pathway of U34. Only steps relevant to this work are shown as understood. The first stage in the modification of U34 at position 5 is
controlled by MnmE and GidA, but it is unclear how many steps precede the formation of cmnm
5U. The cmnm
5 group is then rearranged in two steps catalyzed
by MnmC to synthesize the mnm
5 side chain in some tRNAs. U34 may undergo thiolation at position 2 mediated by MnmA, IscS and other proteins (see text).
It is worthy to mention that the mnmC gene is not evolutionarily conserved, which explains for the absence of mnm
5s
2U in yeast mitochondrial tRNAs.
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ﬁed plasmids. pIC1153 expresses glutathione S-transferase
(GST)-GidA fusion controlled by the Ptac promoter and
LacI
q repressor, and was constructed as follows: gidA was
PCR-ampliﬁed from the chromosome of E.coli MC1000
strain, using Herculase DNA polymerase (Stratagene) and
primers gidA50 (50-GGGGAATTCTCATGTTTTATCCGGA-
TCCTTTT-30) and gidA30 (50-AAAGAATTCCGTTATGCG-
CTACGACGCA-30), incorporating EcoRI restriction sites
(underlined). The resulting 1.9 kb fragment was digested
with EcoRI and ligated to EcoRI digested pGEX-2T.
A recombinant plasmid with proper orientation of gidA
gene was selected. The same 1.9 kb fragment was ligated
to EcoRI digested pJF119EH, rendering pIC1154. This
plasmid carries gidA under the control of Ptac and LacI
q.
Again, a plasmid with proper orientation of insert was
selected. Plasmid pIC1180 produces a FLAG–GidA fusion
under control of promoter PB and protein AraC. It was
constructed as follows: the FLAG epitope coding sequence
(DYKDDDDK) was added in frame to 50 end of gidA
by PCR ampliﬁcation of gidA with primers LY30
(50-GACTACAAGGACGACGATGACAAGATGTTTTATCC-
GGATCCTTTTG-30) and LY31 (50-GCTCTAGATTATGC-
GCTACGACGCAGC-30), coding sequence for FLAG in
cursive and XbaI restriction site underlined. The resulting
1.9 kb fragment was cut with XbaI and inserted into
pBAD22 previously digested with NcoI ﬁlled with Klenow
and then cut with XbaI. Note that the AUG start codon of
the fusion protein is included into the NcoI site, CCATGG,
on the plasmid. Derivatives of pIC1154 and pIC1180
carrying gidA mutations G13A, G15A and G13A/G15A were
obtained by site-directed mutagenesis (QuickChange ,
Stratagene) with appropriate PCR primers. All constructs
were veriﬁed by DNA sequencing. Strain carrying insertion
of Tn10 in position 51 of gidA was a gift from D. Bre ´geon
[see reference (4), mutant number 10].
Media, growth conditions, cellular fractionations and
enzyme assays
LBT (Luria–Bertani broth containing 40 mg/ml thymine) and
LAT (LBT containing 20 g of Difco agar per litre) were used
for routine cultures and plating of E.coli, unless otherwise
speciﬁed. When required, antibiotics were added at the follo-
wing concentrations: 100 mg/ml of ampicillin, 35 mg/ml of
chloramphenicol, 12.5 mg/ml of tetracycline and 80 mg/ml
of kanamycin. Cell growth was monitored by measuring the
optical density (OD) of the cultures at 600 nm. Subcellular
fractions of cells were prepared essentially as described (8).
Glucose-6-phosphate dehydrogenase activity, which was
used as a cytoplasmic marker, was determined as described
previously (34).
Protein techniques and production of antisera
Overproduction of GST-fused GidA was done in DEV16
cells transformed with pIC1153 and pGroESL, grown during
1 4ha t2 5  C with 10 mM isopropyl-b-D-thiogalactopyra-
noside (IPTG). GidA puriﬁcation was carried out using
afﬁnity chromatography with glutathione-agarose and further
Table 1. E.coli strains and plasmids used in this study
Strain or plasmid Description Origin and/or reference
E.coli strains
DEV16 F
  thi-1 rel-1 spoT1 lacZ105UAG mnmEC3676T [MnmEQ192X, Val
R] (5)
DH5a F
  endA1 hsdR17 supE44 thi1 recA1 gyrA relA1 D(lacZYA-argF) U169(F80lacZDM15) (42)
MC1000
MG1655 F
  D. Touati
IC4639 DEV16 mnmE
+ bgl (Sal
+) M. Villarroya
IC5241 MG1655 gidA::Tn10 [Tet
R] This work
IC5242 IC5241 carrying pIC1154 [GidA
+, Tet
R,A p
R] This work
IC5244 IC5241 carrying pIC1177 [GidA G13A, Tet
R,A p
R] This work
IC5245 IC5241 carrying pIC1178 [GidA G15A, Tet
R,A p
R] This work
IC5246 IC5241 carrying pIC1179 [GidA G13A/G15A, Tet
R,A p
R] This work
IC5287 XL1 carrying pIC931 [Ap
R] This work
IC5332 DH5a carrying pIC1154 [Ap
R] This work
IC5358 MG1655 mnmE::kan [MnmE
 , Kan
R] (10)
IC5550 IC4639 gidA::Tn10 [Tet
R] This work
V5701 bgl (Sal
+) (7,43)
Plasmids
pBAD22 Expression vector with PB and AraC control (Ap
R) (44)
pGEX-2T Cloning vector for GST fusions (Ap
R) Pharmacia Biosciences
pGroESL groES and groEL genes cloned under Ptac (Cm
R) (45)
pJF119EH Expression vector with Ptac and LacI
q control (Ap
R) (46)
pIC684 GST fusion of mnmE (cloned in pGEX-2T) (7)
pIC931 mnmE cloned under Ptac[Ap
R] M. Villarroya
pIC1153 GST fusion of gidA (GST-GidA
+ fusion, cloned in pGEX-2T) This work
pIC1154 gidA inserted into EcoRI site of pJF119EH This work
pIC1177 pIC1154 derived plasmid containing gidAG13A This work
pIC1178 pIC1154 derived plasmid containing gidAG15A This work
pIC1179 pIC1154 derived plasmid containing gidAG13AG15A This work
pIC1180 FLAG-gidA inserted between sites NcoI and XbaI of pBAD22 This work
pIC1181 pIC1180 derived plasmid containing FLAG-gidAG13A This work
pIC1182 pIC1180 derived plasmid containing FLAG-gidAG15A This work
pIC1183 pIC1180 derived plasmid containing FLAG-gidAG13AG15A This work
5894 Nucleic Acids Research, 2006, Vol. 34, No. 20thrombin cleavage, essentially as described (7). Cleavage of
the chimera with thrombin rendered two isolated proteins;
the 69 kDa expected one and another of lower molecular
weight, probably due to internal protease cleavage. The
69 kDa protein was excised from SDS–acrylamide gels and
used to inoculate New Zealand rabbits. The resulting
antiserum was afﬁnity puriﬁed with PVDF-bound GidA
before use. SDS–PAGE and immunoblotting were carried
out essentially as described (7). Puriﬁcation of GST-GidA
for pull down assays was done as mentioned above except
that no thrombin digestion was performed and elution of
the protein was achieved with free glutathione buffer. Puri-
ﬁcation of GST-MnmE or recombinant MnmE (rMnmE,
53 kDa) for pull down assays was done from DEV16
transformed with pIC684 as described previously (7).
Overproduction of FLAG-GidA and mutant derivatives was
achieved by growing strain DH5a transformed with
pIC1180, pIC1181, pIC1182 or pIC1183, during 3 h at
37 C in LBT containing 0.2% arabinose and ampicillin.
In these conditions, FLAG-GidA and derivatives were
almost completely soluble so there was no need of chaperone
co-expression. Cells were collected, disrupted by sonication,
centrifuged and the supernatant (cleared lysate) applied over
anti-FLAG M2 agarose (Sigma). The lysate was passed
four times through the resin. After collecting the ﬂow
through, the resin was washed with 3 · 8 column volumes
of TBS [50 mM Tris–HCl (pH 7.5) and 150 mM NaCl].
FLAG-GidA proteins were eluted with ﬁve column volu-
mes of TBS containing 0.1 mg/ml of FLAG peptide (Sigma).
Normally, two eluates were collected. Proteins were
quantiﬁed by Bradford assay using BSA as standard.
Overproduction of FLAG-GidA used in pull down assays
was performed in DEV16 transformed with pIC1180, to
avoid carrying endogenous MnmE protein with puriﬁed
FLAG-GidA. Production of the anti-MnmE and anti-CyoA
antibodies was described previously (7,8).
Gel filtration chromatography, native PAGE and
in vitro cross-linking
Gel ﬁltrations were performed using a Superdex 200 HR10/
30 column (Amersham Biosciences) in 100 mM NaPO4
(pH 7.0), 150 mM NaCl, containing or not 5 mM DTT, at
a ﬂow rate of 0.2 ml/min. Gel ﬁltration markers were used
to calibrate the column. Proteins were detected by ultraviolet
(UV) absorbance at 280 nm. Aliquots of selected fractions
were analysed by SDS–PAGE and, in some cases, native
PAGE. Gels and buffers used for native PAGE were made
according to the standard Laemmli SDS protocol omitting
the SDS. Native gels (10% polyacrylamide) were run at
4 C for 3.5–4 h at 15 mA, and stained with Coomassie
blue or analysed by immunoelectroblotting using appro-
priate antibodies. To determine the stoichiometry of the
MnmE GidA complex, proteins FLAG-GidA and rMnmE
were mixed, at 5 mM each, and incubated for 2 h at room
temperature in phosphate-buffered saline (PBS) containing
2 mM MgCl2 and 5 mM DTT. Samples of the mix and
each protein alone were analysed by gel ﬁltration, in
the presence of 5 mM DTT, or native PAGE. In vitro
cross-linking experiments were performed as described
previously (7).
GST-pull down assays
GST-GidA, GST-MnmE or GST were expressed from
plasmids pIC1153, pIC684 and pGEX-2T, respectively, and
bound to glutathione-agarose as described previously (7).
Total cleared lysates of cells transformed with plasmids
pIC931 (expressing mnmE) or pIC1154 (expressing gidA),
induced during 2 h with 0.5 mM IPTG, were obtained,
pre-incubated with glutathione-agarose and added to resin-
bound GST-GidA or GST-MnmE, respectively. As a control,
equal amounts of both lysates were added to resin-bound
GST. Reactions were incubated 2 h at room temperature
with gentle agitation and after collecting the unbound
fraction, and washing extensively the beads with PBS
containing 0.05% Triton X-100, the bound material was
eluted with 50 mM Tris–HCl (pH 8), 10 mM glutathione.
Equal amounts of samples from each reaction were analysed
by immunoblotting using appropriate antibodies.
FLAG-pull down assays
Proteins FLAG-GidA and rMnmE, at a ﬁnal concentration of
5 mM each, were incubated together for 2 h in PBS, at room
temperature. Then, anti-FLAG agarose was added, and the
mixture incubated overnight at 4 C with gentle agitation.
As a control, rMnmE was incubated with anti-FLAG agarose
without FLAG-GidA added. After collecting the unbound
fraction, beads were extensively washed with PBS and the
remained material eluted with PBS containing 0.1 mg/ml
FLAG peptide. Equal amounts of samples from each experi-
ment were analysed by SDS–PAGE, and the proteins detected
with Coomassie blue stain.
Cofactor analysis
UV-visible spectral analysis of puriﬁed proteins (at a concen-
tration  0.3 mM) were performed in a NanoDrop ND-1000
spectrophotometer (NanoDrop Technologies, Rockland),
scanning from 220 to 750 nm. Flavine was released from
FLAG-GidA by heating at 75 C for 15 min in the dark
and analysed by high-performance liquid chromatography
(HPLC) as described (35) with minor modiﬁcations. Brieﬂy,
HPLC separation was achieved with a Lichrospher
R 100
RP-18 (5 mm) using a linear gradient of water [5 mM
NH4Oac (pH 6.0)] methanol (10%) to water [5 mM
NH4Oac (pH 6.0)] methanol (70%) developed over 35 min
at a ﬂow rate of 1.2 ml/min. Flavins were detected by
ﬂuorescence emission using a Waters 2475 multi l ﬂuores-
cence detector. Detector wavelengths were set at 450 nm
for excitation and 525 nm for emission.
Analysis of tRNA modification by HPLC
Strains MG1655 (wild-type) and derivatives IC5241
(gidA::Tn10) and IC5358 (mnmE::kan) were grown until
late log phase in LBT, then cells were collected and
processed as described previously for nucleoside analysis
(10). IC5241 cells carrying plasmids pIC1154 (gidA
+),
pIC1177 (gidA G13A), pIC1178 (gidA G15A) and pIC1179
(gidA G13A/G15A) were grown during 3 h with or without
inducer (1 mM IPTG), before being collected and processed
as above. Note that LBT is deﬁcient in selenium; thus,
MnmE/GidA-speciﬁc tRNAs isolated from strains grown in
this medium mostly carry sulfur at position 2.
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GidA antibody production and subcellular localization
M.xanthus carries genes encoding both TrmFO and GidA
proteins, which share about 25% identity in their N-terminal
450 amino acids (1). Subcellular fractionation followed by
immunoblotting with anti-TrmFO antibody led to the idea
that the M.xanthus GidA protein is localized in periplasm,
or in association with the inner membrane, since the anti-
TrmFO antibody reacted slightly with a protein of 75 kDa,
the expected size for GidA (1). No null gidA mutant was
available to be introduced as a negative control in these
experiments. Moreover, it was observed that M.xanthus
GidA does not have any regions that score well as membrane-
spanning segments, nor does it have an N-terminal sequence
that resembles a signal peptide (1). Therefore, the putative
periplasmic localization of M.xanthus GidA remains to be
checked.
Periplasm is not the expected localization for an enzyme
involved in tRNA modiﬁcation. Thus, immunoelectron
microscopy and subcellular fractionation revealed that the
E.coli MnmE protein is a cytoplasmic protein partially
associated with the inner membrane (7,8). Here, it was of
interest to determine the localization of E.coli GidA, and to
this end, an anti-GidA antibody was generated. GidA was
expressed as a protein fused to the C-terminal region of the
GST, but the GST–GidA chimera (96 kDa) was only soluble
in the presence of overproduced GroES and GroEL chaper-
ons. Cleavage with thrombin of the chimera, after puriﬁca-
tion by afﬁnity chromatography, allowed the isolation of a
recombinant GidA with the expected mass of about 69 kDa
that was used to raise antibodies in rabbits. Speciﬁcity of
the anti-GidA antibody was tested in strains IC4639 and
IC5550, which carry the wild-type and gidA::Tn10 allele,
respectively (Figure 2A).
E.coli strains either expressing GidA at wild-type levels
(IC4639) or lacking GidA (IC5550) were subjected to subcel-
lular fractionation followed by immunoblotting to identify
GidA in the fractions. As shown in Figure 2B, GidA was
mostly found in the soluble fraction, although at least
a portion was also detected in the membrane fraction.
Activity of glucose-6-phosphate dehydrogenase, used as a
cytoplasmic marker, was negligible in the membrane fraction
(lanes M), indicating little, if any, cross-contamination with
the soluble fraction (lanes S). These results altogether
support that, in E.coli, GidA and MnmE display identical
localization.
Self-association of GidA
It has been recently reported that the B.subtilis TrmFO
protein forms homodimers in vitro (2). Given that TrmFO
and GidA proteins share about 25% identity (40% similarity)
in their N-terminal homologous region, we asked whether
E.coli GidA is also able to dimerize. To this end, puriﬁed
FLAG-GidA protein (Figure 3A) was applied to a Superdex-
200 HR gel ﬁltration column. As shown in Figure 3B, FLAG-
GidA protein eluted as a single peak at  168 kDa, which is
consistent with a dimeric form of this protein (expected
molecular weight, 141 kDa). An identical result was obtained
from gel ﬁltration experiments performed in the presence of
DTT, 5 and 10 mM (data not shown), which supports
that GidA homodimers may be maintained by non-covalent
interactions.
The ability of GidA to dimerize was also analysed by
in vitro chemical cross-linking. Extensive cross-linking in
solution is taken to be indicative of speciﬁc interactions,
since random collisions are expected to produce a minimal
amount of cross-linking [(7) and references therein]. Dithio-
bis (succinimidyl propionate) (DTSP) was used as the
cross-linking molecule; it reacts primarily with e-amines of
lysine residues, and is cleavable under reducing conditions.
Incubation of FLAG-GidA with DTSP led to the forma-
tion of a complex of around 150 kDa, (Figure 3C, compare
lanes 2 and 3), whereas the subsequent addition of the strong
reducing agent 2-mercaptoethanol (2-ME) induced dissocia-
tion into monomers (Figure 3C, compare lanes 3 and 5).
GidA and MnmE interact and form an a2b2
heterotetrameric complex
Several results indicate that both GidA as well as MnmE form
homodimers in vitro (Figure 3B and C; 7–9). Previously, it
was observed that when a mitochondrial extract obtained
from a yeast transformant overexpressing proteins MTO1
and MSS1 was centrifuged through a sucrose gradient, the
two proteins displayed identical sedimentation properties
(29). Considering that MTO1 and MSS1 peaked in a region
Figure 2. (A) Specificity of the anti-GidA antibody. Equal amounts of total
extracts of strains IC4639, IC5550 and IC5550 harbouring plasmid pIC1154
(where gidA is under control of Ptac promoter and LacI repressor) were
subjected to western blot analysis using anti-GidA antibody. Strain IC5550/
pIC1154 was grown in the absence of inducer IPTG, but there is escape of
gidA expression. Molecular weight markers (on the left) are in kDa. (B)
Subcellular localization of GidA. Western blot analysis with anti-GidA and
anti-CyoA antibodies of cell fractions from strains IC4639 and IC5550 is
shown. Equal amounts of bulk protein (50 mg) were loaded in each lane. T,
total cell lysate; S, soluble fraction; M: membrane fraction.
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hemoglobin markers, it was concluded that they form a
heterodimer complex with a molecular weight of around
121–128 kDa. However, because of these experiments did
not include appropriate controls showing the sedimentation
properties of each protein alone, and in the light of the new
results, we thought that other explanations were also possible.
For example, it could not be discarded that the gradient
fraction supposed to contain the putative heterodimer,
actually included MTO1 and MSS1 homodimers. In this
respect, it is worthy to mention that the MnmE dimer has
an elongated structure, which determines that it migrates in
gel ﬁltration at a molecular mass greater than expected (9).
Consequently, it would not be surprising that a dimer of
its homologue, MSS1, could also display an anomalous
sedimentation proﬁle, peaking at a position similar to that
of a putative MTO1 dimer. We also reasoned that complexes
between MTO1 and MSS1 homodimers, if exist, could
not have been detected by sucrose gradient centrifugation
because they might be sensitive to pressure and dissoci-
ate during high velocity centrifugation. Alternatively, it
could not be either discarded the possibility that the
MSS1 MTO1 complex displayed aberrant sedimentation
properties, so that the putative heterodimer were actually a
heterotetramer. Thus, we considered that additional experi-
ments were required to prove and clarify interaction between
the MnmE and GidA family proteins.
To explore whether the E.coli MnmE and GidA proteins
physically interact, we performed GST-pull down analysis
using puriﬁed GST-MnmE or, alternatively, GST-GidA as
a bait. GST-MnmE immobilized on glutathione-agarose
beads was incubated with total protein extracts of a GidA
overexpressing strain. As can be seen in Figure 4A, GidA
could be pulled down from the extracts by GST-MnmE but
not by GST alone. Moreover, protein EF-Tu, used as a
control, was detected only in the unbound supernatant
fraction (data not shown). Conversely, when GST-GidA
was used as a bait, MnmE was pulled down from a total
extract of an MnmE overproducing strain meanwhile, in the
same conditions, MnmE was not pulled down by GST
alone (Figure 4B). These results suggest that MnmE and
GidA interact with each other in total E.coli extracts;
however, they do not inform whether such an interaction is
direct or mediated by another protein. In addition, the need
to co-overproduce chaperones to obtain soluble GST-GidA
protein raises the possibility that some chaperone mediates
interaction of MnmE with GST-GidA. Therefore, we deci-
ded to perform co-immunoprecipitation experiments using
FLAG-GidA protein as bait. This protein is overproduced
by adding arabinose to the medium and remains mostly solu-
ble, eliminating the requirement for chaperone co-expression
(see Figure 3A). We puriﬁed FLAG-GidA by ﬁrstly passing
it through an anti-FLAG agarose column and later eluting
it with excess of FLAG peptide. When analysing the
fractions eluted from the column by Western blotting
(Figure 4C), we observed that MnmE, but not EF-Tu, was
co-eluted with FLAG-GidA, supporting that MnmE and
FLAG-GidA were able to interact in total extracts of E.coli.
Moreover, we used puriﬁed FLAG-GidA as bait to pull down
puriﬁed recombinant MnmE (rMnmE, molecular mass,
53 kDa). As shown in Figure 4D, rMnmE is pulled down with
Figure 3. Self-assembly of FLAG-GidA protein. (A) Purification of the
recombinant protein FLAG-GidA. SDS–PAGE analysis of samples from
different purification steps of the FLAG-GidA protein. The gel was stained
with Coomassie blue. Lane 1, crude extract from uninduced DEV16/pIC1180;
lane 2, crude extract from DEV16/pIC1180 induced with arabinose; lanes 3
and 4, cleared lysate (supernatant after sonication) and insoluble material
(pellet after sonication) of the induced strain, respectively; lane 5, first eluate
with elution buffer (containing free FLAG peptide); lane 6, second eluate
with elution buffer. (B) Gel filtration analysis of purified FLAG-GidA. A
total of 100 mg of FLAG-GidA were applied on a Superdex HR 200 column
as described in Materials and Methods and 0.5 ml fractions collected.
Markers indicate the positions of the standards: ferritin (440 kDa), b-amylase
(224 kDa), aldolase (158 kDa), albumin (67 kDa). Inset: SDS–PAGE analysis
of fractions indicated with asterisks in the chromatogram and designated as
a, b, and c. (C) In vitro cross-linking of FLAG-GidA with DTSP. Protein
samples, untreated or cross-linked with DTSP, were analysed by non-
reducing SDS–PAGE. Lanes 4 and 5 show the effect of 2-ME on the
reactions. Size of mass markers, run in lane 1, is indicated on the left in kDa.
Nucleic Acids Research, 2006, Vol. 34, No. 20 5897anti-FLAG agarose only when FLAG-GidA is present, and is
eluted from the resin using an excess of FLAG peptide. We
therefore conclude that the E.coli MnmE and GidA proteins
are able to directly interact with each other.
Next, considering that both MnmE and GidA alone
dimerize, we decided to investigate the stoichiometry of
the GidA MnmE complex. To this end, puriﬁed rMnmE
(53 kDa) and FLAG-GidA (70.4 kDa) proteins were applied,
either separately or jointly, to a Superdex-200 HR gel ﬁltra-
tion column. Figure 5A shows that rMnmE and GidA eluted
as single peaks at molecular weights of 149 and 168 kDa.
Figure 4. GidA and MnmE interact with each other. (A) Western blot of GST
pull down analysis using anti-GidA antibody. GST-MnmE or GST alone were
used as baits for pull down analysis. Input: total lysate of strain IC5332 that
was added to the corresponding bait previously immobilized to glutathione-
agarose. Sup: fraction not retained by the resin-bound bait protein. El:
the bound material that is eluted from the resin with glutathione buffer.
Equivalent amounts of each fraction were loaded. (B) The same as in (A),
but the baits were GST-GidA or GST, the lysate was from strain IC5287, and
the western blot was developed with anti-MnmE antibody. (C) Coimmuno-
purification of FLAG-GidA and MnmE. FLAG-GidA was purified from
strain DH5a/pIC1180 with anti-FLAG agarose as described in Materials and
Methods, and the resulting fractions were analyzed by western blot using the
antibodies indicated in the right side of each panel. Anti-EF-Tu was used as
a negative control. The arrowhead marks MnmE position. The upper band
detected in the MnmE western blot corresponds to an unrelated, unknown
protein that is recognized by the anti-MnmE antibody and serves as a negative
control. CL: cleared lysate of DH5a/pIC1180 (supernatant after sonication).
Ins: pellet of cleared lysate. FT: flow through after incubation with
anti-FLAG agarose. R: resin after washes. El 1: first eluate with elution
buffer (free FLAG peptide). El 2: second eluate with elution buffer. (D)
In vitro pull down analysis of purified recombinant MnmE (rMnmE) and
FLAG-GidA proteins. After incubating both proteins together, anti-FLAG
resin was added and fractions collected as described in Material and Methods.
As a negative control, MnmE was processed without adding FLAG-GidA.
Sup: supernatant after pelleting FLAG-agarose. El: proteins eluted with free
FLAG peptide. Equivalent amounts of samples were loaded in each well. Size
of molecular weight markers (MWM) is indicated on the left in kDa.
Figure 5. GidA and MnmE form an a2b2 heterotetrameric complex. (A)
Estimation of the molecular mass of the peak fractions in preparations of
rMnmE, FLAG-GidA and a FLAG-GidA/rMnmE mix by gel-filtration
chromatography. The major peaks from each preparation eluted at 149, 168
and 195 kDa, respectively. Markers indicate the positions of the standards:
ferritin (440 kDa), b-amylase (224 kDa), aldolase (158 kDa), albumin
(67 kDa). Elution fractions a to g from chromatography of the FLAG-GidA/
MnmE mix were pooled for further analysis. (B) SDS–PAGE of elution
fractions a to g from the FLAG-GidA/rMnmE mix chromatography showed
in (A). Fractions (250 ml) were precipitated with trichloroacetic acid before
loading. The gel was stained with Coomassie blue. Molecular masses are
indicated on the right in kDa. (C) Native PAGE analysis of rMnmE, FLAG-
GidA and a mix of FLAG-GidA/rMnmE. Lane 1: Molecular mass markers
were b-amylase and albumin (monomer and dimer). Lane 2: 10 mgo f
rMnmE. Lane 3: 10 mg of FLAG-GidA. Lanes 4–6: 15, 30, and 40 mg,
respectively, of total protein from a FLAG-GidA/rMnmE mix prepared as
indicated in Materials and Methods. Positions of mass markers and their size
in kilodaltons are indicated on the left. Positions of rMnmE, FLAG-GidA and
FLAG-GidA rMnmE specific complexes are indicated on the right, together
with the apparent molecular mass of the complexes. (D) Native PAGE of
fractions coming from gel-filtration of a FLAG-GidA/rMnmE mix. Lane 1:
molecular mass markers were as (C), Lanes 2 and 3: elution fractions b and c,
respectively, from an experiment like that shown in (A). Size of the mass
markers and complexes are indicated on the right and left, respectively. Note
correspondence between complexes detected here and those of (C).
5898 Nucleic Acids Research, 2006, Vol. 34, No. 20Note that the estimated mass of MnmE is larger than
expected, but this feature has been previously described and
considered to be due to the elongated shape of the MnmE
dimer (9). When a mix of GidA and MnmE was chro-
matographed, both proteins coeluted at a peak of about
195 kDa, which is indicative of their presence in a complex
(Figure 5A). Moreover, given that this analysis was per-
formed in the presence of DTT, 5 mM, it may be concluded
that the in vitro formation of the GidA MnmE complex
does not involve disulﬁde bridges. From these results, and
considering that: (i) the apparent mass of the complex is
larger than that of each homodimer, (ii) no peaks corres-
ponding to monomeric forms are distinguishable from the
elution proﬁle of the mix, and (iii) the peak of the mix
(elution fraction c) contains approximately equal amounts
of GidA and MnmE (Figure 5B), we propose that the peak
of 195 kDa corresponds to a GidA MnmE heterotetrameric
complex of type a2b2, whose compact conformation results
in an apparent mass smaller than expected. To conﬁrm this
proposal, we analysed migration of a GidA/MnmE mix in
native gels. As shown in Figure 5C, puriﬁed rMnmE and
FLAG-GidA proteins migrate, when separately loaded, at
positions corresponding to a molecular mass of 102 and
171 kDa, respectively. Note that in this case, the apparent
mass of MnmE ﬁts well with that expected for its dimeric
form. The mix of MnmE and GidA produces bands of 102,
171 and 250 kDa. Since the last one is recognized by both
anti-MnmE and anti-GidA antibody (data not shown), and
its size ﬁts well with the sum of sizes of the MnmE and
GidA homodimers, as estimated from their migration in
the same native gel, we conclude that it corresponds to the
a2b2 heterotetrameric form of the GidA MnmE complex.
It is worthy to mention that, when samples of the elution frac-
tions b and c from the gel ﬁltration experiment (Figure 5A)
were analysed by native PAGE, a predominant 250 kDa
band was also observed (Figure 5D, lanes 2 and 3), which
supports the idea that the apparent mass of the heterote-
trameric GidA MnmE complex estimated from gel ﬁltration
is smaller than that estimated from native PAGE.
The FAD domain of GidA is required for the tRNA
modifying function of this protein
Alignment of Gid proteins in the database reveals a highly
conserved dinucleotide-binding motif [xhxhxGxGxxG(x)3-
hxxh(x)9hxhxxE/D, where x is any residue and h is a
hydrophobic residue] near the N-terminus (1,2). In fact, the
TrmFO proteins from M.xanthus and B.subtilis (1,2) and
GidA proteins from B.subtilis and E.coli (2,9) were reported
to bind FAD. In this study, we have found that FLAG-GidA
absorbs at about 340 and 430 nm (Figure 6A), in agreement
with the idea that GidA binds ﬂavin. Moreover, HPLC anal-
ysis indicated that the cofactor released from FLAG-GidA by
heating the protein at 75 C for 15 min was FAD (Figure 6A,
inset). In contrast, the visible spectrum of MnmE, the GidA
partner in the modiﬁcation reaction, reveals that this protein
does not contain ﬂavin (Figure 6C).
The dinucleotide-binding motif present in the N-terminal
end of GidA is known to be part of the Rossmann fold
characteristic of the glutathion reductase family (36). The
importance of the invariant glycine residues (GxGxxG) in
this motif is well understood, with the two ﬁrst glycines
determining close contact of the main chain to the pyro-
phosphate of FAD (36). In agreement with this, when we
separately changed these invariant glycines to alanine on
FLAG-GidA, the UV-visible spectrum of the puriﬁed proteins
G13A (from plasmid pIC1181) and G15A (from plasmid
pIC1182) indicated that the absorbing peaks at around 340
and 430 nm were signiﬁcantly lower than those produced
by the wild-type protein (Figure 6D and E), suggesting that
both mutant proteins bind FAD in less extent than the wild-
type GidA (Figure 6A).
To determine whether the FAD-binding motif of GidA is
involved in the tRNA modifying function of this protein, we
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Figure 6. Spectral analysis of purified FLAG-GidA and mutant derivatives,
to detect the presence of bound FAD. The UV-visible spectrum of the wild
type, G13A, and G15A FLAG-GidA proteins is shown in panel A, D and E,
respectively. Free FAD was used to obtain a reference spectrum (panel B),
and rMnmE as a negative control (panel C). Insets: HPLC analysis of the
GidA-bound cofactor (A) and FAD (B), which had retention times of 16.19
and 16.05 min, respectively. FMN had a retention time of 18.61 min (data not
shown).
Nucleic Acids Research, 2006, Vol. 34, No. 20 5899introduced mutations G13A and G15A on plasmid pIC1154
(carrying the gidA wild-type gene under control of promoter
Ptac) and proceeded to analyse the nucleoside composition of
tRNA from strains producing wild-type or mutant GidA
proteins. First, total tRNA from strains MG1655 (wild-type)
and IC5241 (MG1655 gidA::Tn10) was hydrolysed and
analysed by HPLC. As can be seen in Figure 7A, a peak
corresponding to nucleoside mnm
5s
2U is detected in tRNA
from strain MG1655, but not in tRNA isolated from
IC5241. Conversely, a peak corresponding to s
2U is seen in
tRNA from IC5241, but not in tRNA from the wild-type
strain. This indicates that in the gidA::Tn10 strain, the
addition of cmnm group in position 5 of U34 is defective,
rendering U34 modiﬁed only in position 2 (see Figure 1).
Note that this pattern is similar to that observed in tRNAs
obtained from the mnmE::kan strain (10; Figure 7A, lower
panel). These results show for the ﬁrst time that interruption
of the gidA gene impairs formation of mnm
5s
2U34, and
deﬁnitively prove that gidA is allelic to trmF (see Introduc-
tion). In this respect, it should be pointed out that the origi-
nal proposal by Bre ´geon et al. (4) that trmF and gidA are
allelic was mostly based on genetic mapping data, (which
were not precise in the trmF case) as well as on phenotypic
traits. Next, we analysed the nucleoside composition of
strains producing mutant GidA proteins. Thus, total tRNA
from strain IC5241 (MG1655 gidA::Tn10) transformed with
pIC1154 (Ptac-gidA) or each one of its mutant derivatives
(pIC1177, pIC1178 and pIC1179 carrying alleles G13A,
G15A or G13A/G15A, respectively), and grown with or
without IPTG, was hydrolysed and analysed by HPLC. As
shown in Figure 7B (without IPTG, left panels), a peak
corresponding to s
2U is detected in the analysis of tRNA
from strains G13A, G15A and G13A/G15A, although it is
most prominent in the last one. This pattern is indicative of
a defect in the addition of the cmnm group to position 5 of
U34 (see Figure 1), as shown in the analysis of strain
gidA::Tn10 (Figure 7A). Note, however, that a small peak
corresponding to mnm
5s
2U34 is present in tRNA isolated
from mutants G13A, and G15A but not in tRNA isolated
from G13A/G15A (Figure 7B, left panels). This suggests
that even in the absence of the IPTG inducer, a certain
amount of protein G13A or G15A is produced, which is
able to modify a fraction of tRNA molecules. When tRNA
is isolated from IPTG-induced G13A and G15A strains
(Figure 7B, right panels), the peak corresponding to s
2U
decreases whereas that corresponding to mnm
5s
2U increases.
This behaviour is not observed with tRNA isolated from
mutant G13A/G15A, which suggests that the GidA protein
produced by this mutant is a full loss-of-function protein.
Western blot analysis conﬁrmed production of the mutant
proteins even in the absence of the IPTG inducer, which
is probably due to an incomplete repression of the strong
promoter Ptac (Figure 8,  IPTG). No signiﬁcant differences
among cellular levels of the plasmid encoded wild-type and
mutant proteins were observed both in the presence as well
as in the absence of IPTG (Figure 8), indicating that the
defects in tRNA modiﬁcation observed in cells expressing
mutant proteins (Figure 7B) are not due to a lower accumu-
lation of these proteins into the cell. It is also interesting
to note that the cellular levels of proteins G13A and G15A
synthesized in the absence of IPTG were similar to the
native levels of GidA in strain MG1655 (Figure 8,  IPTG).
This supports that proteins G13A and G15A are not as
effective as the native GidA protein in conducting tRNA
modiﬁcation since s
2U is present in tRNA puriﬁed from
strains expressing proteins G13A and G15A (Figure 7B,
left panels), but not in tRNA obtained from the wild-type
strain (Figure 7A). Moreover, a small but discernible peak
of s
2U is still detected from tRNA of strains overexpressing
proteins G13A and G15A (Figure 7B, right panel), in spite
of their respective cellular levels are much higher than the
native levels of GidA (Figure 8, +IPTG). Therefore, it is
reasonable to conclude that G13A and G15A are partial
loss-of-function proteins.
Phenotype of GidA mutants
Full loss-of-function mnmE mutations are lethal in the genetic
backgrounds of strains JC7623 and V5701 but not in those of
MC1000, DEV16 and MG1655 (7,8,10). At present, we have
demonstrated that the lethal phenotype results from incom-
patibility of loss-of-function mnmE mutations with mutations
in genes involved in the ribosomal dynamic (M. Villarroya,
L. Yim and M.-E. Armengod, manuscript in preparation).
Here, we have found that the gidA::Tn10 allele cannot be
recovered on the V5701 chromosome after P1 transductions
unless the receptor strain carries a second copy of gidA on
a plasmid that allows accumulation of the wild-type, G13A
or G15A GidA protein (i.e. plasmids pIC1154, pIC1177
and pIC1178; data not shown). This indicates that the
gidA::Tn10 null allele is also lethal in the V5701 background
and that the single mutations G13A and G15A should be par-
tial loss-of-function mutations, given that overexpression of
the corresponding proteins allows recovery of allele
gidA::Tn10 on the V5701 chromosome. It should be pointed
out that overexpression of protein G13A/G15A (from plasmid
pIC1179) does not lead to recovery of allele gidA::Tn10,
which means that it is not able to complement for the null
allele and, therefore, that mutation G13A/G15A is a full
loss-of-function mutation.
Note that, similarly to full loss-of-function mnmE muta-
tions (7,8,10), the G13A/G15A or gidA::Tn10 mutations
could be recovered on the DEV16 or MG1655 chromosome
even in the absence of a second copy of the wild-type gidA
gene (see e.g. strains IC5241 and IC5550 in Table 1).
Interestingly, the cell growth is slowed down by about
30% when mutation gidA::Tn10 is introduced into strain
MG1655, and this effect can be suppressed by a plasmid
overexpressing protein G13A or G15A but not by a plasmid
overexpressing protein G13A/G15A (data not shown). This
indicates that mutation G13/G15 affects cell growth in the
same extent than a null gidA mutation does, which is in
agreement with the idea that G13/G15 is a full loss-
of-function mutation.
We have also found that mutations gidA::Tn10 and
mnmE::kan reduce the doubling time of strain MG1655 to
a similar extent in LB (doubling times: 29.9 ± 2.3, 37.8 ±
2.7 and 38.2 ± 3.1, for wild-type, mnmE and gidA strains,
respectively), minimal medium supplemented with casami-
noacid (doubling times: 50.3 ± 3.6, 63.7 ± 4.1 and 64.1 ±
4.2, for wild-type, mnmE and gidA strains, respectively),
and minimal medium, in which both mutations seem to
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Figure 7. HPLC chromatograms of tRNA hydrolysates. Strains used were: MG1655 (wild-type), IC5241 (gidA::Tn10), and IC5348 (mnmE::kan), in (A), and
IC5241 transformed with plasmids pIC1154, pIC1177, pIC1178 and pIC1179 (carrying the wild-type, G13A, G15A and G13A/G15A gidA allele, respectively),
in (B). Strains in (B) were grown with (+, right side) or without ( , left side) IPTG. The nucleosides were monitored at 314 nm to maximize the detection of
thiolated nucleosides. mnm
5s
2U and s
2U were identified by comparing UV spectra with published spectra (41). AU, absorbance units.
Nucleic Acids Research, 2006, Vol. 34, No. 20 5901have a minor effect (doubling times: 90 ± 5.5, 103.1 ± 5.9 and
100.2 ± 4.5, for wild-type, mnmE and gidA strains, respec-
tively). Curiously, Bre ´geon et al. (4) found that whilst the
growth rate of their gidA::Tn10 and mnmE::Tn10 mutants
was reduced in LB to the same level, only mutation
gidA::Tn10 signiﬁcantly reduced the growth rate in minimal
medium. This difference of phenotype conferred by gidA and
mnmE mutations led Bre ´geon et al. (4) to propose that the
MnmE activity precedes that of GidA in the tRNA modiﬁca-
tion pathway, and that accumulation of the unknown product
of MnmE in gidA mutants could be toxic for cells under slow
growth conditions. If MnmE worked before GidA, we should
ﬁnd a reduction of the s
2U levels in gidA::Tn10 mutants since
the hypothetical MnmE product would be generated in these
mutants at expenses of s
2U (see Figure 1). However, we
have found that the levels of s
2U are near identical in full
loss-of-function gidA and mnmE mutants (Table 2). There-
fore, our results do not support the idea that the MnmE activ-
ity precedes that of GidA. Moreover, as above pointed out,
we have not found signiﬁcant differences between the growth
rate of gidA and mnmE mutants in minimal medium. The
discrepancy between these results and those reported by
Bre ´geon et al. (4) might be due to the use of different
insertion mutations. Our strains carry the Tn10 insertion at
position 51 in gidA, whereas Bre ´geon et al. used a gidA
mutant carrying the Tn10 insertion at position 707 for
their experiments. In both insertions, the orientation of the
minitransposon remains to be determined. Minitransposons
may be polar and their effect on neighbouring genes may
depend on their location and orientation within the target
gene. Therefore, it is possible that the effect of each Tn10
insertion on gidA neighbouring genes (i.e. oriC and gidB,
which encodes a putative methyltransferase of unknown
function) were different, and this may be the true cause of
the different behaviour of gidA insertion mutants in minimal
medium. Since plasmid pIC1154, which just carries the
structural gidA gene under control of a suitable promoter,
reverted the growth rate of our gidA::Tn10 mutant to the
wild-type level, we are conﬁdent that, in this strain, the
polar effects of the minitransposon, if there exist, are negligi-
ble. Consequently, our data support the conclusion that
loss-of-function gidA and mnmE mutations have similar
effects on cell growth (including the synthetic lethality phe-
nomenon and growth rate, see above) and the tRNA modiﬁca-
tion status (Table 2).
DISCUSSION
The role of tRNA in mRNA decoding is crucial to the
accuracy and efﬁciency of protein synthesis. The post-
transcriptional modiﬁcations that occur at the wobble position
of tRNAs that read codons in the mixed codon boxes are
particularly signiﬁcant (16,37,38). E.coli mutants defective
in the biosynthesis of mnm
5s
2U, the modiﬁed nucleoside
that is present in the wobble position of tRNAs speciﬁc for
Lys and Glu, were ﬁrstly isolated based on the readthrough
phenotype at UAG codons (5). This allowed the characteriza-
tion of the trmE and trmF loci, which were mapped to two
different locations on the E.coli chromosome, although the
phenotype of both type of mutants was quite similar. The
isolation and study of trmC (mnmC) mutants allowed to
conclude that trmF and trmE control the addition of the
cmnm group in position 5 of the wobble uridine (6; see
Figure 1). Later, the trmE gene was shown to be allelic
with a gene encoding a 50 kDa GTPase, and renamed
mnmE (7), whereas trmF was proposed to be allelic with
gidA from indirect genetic evidence and phenotypic traits
(4). However, no analysis of the tRNA modiﬁcation status
in gidA mutants has been performed up to now. In this
study, we show for the ﬁrst time that mutations in the
E.coli gidA gene impair the biosynthesis of mnm
5s
2U
(Figure 7) and, therefore, deﬁnitively prove that gidA is
allelic to trmF. The tRNA modifying function assigned to
gidA is in agreement with recent ﬁndings in yeast showing
that disruption of the gidA homologous gene, MTO1, impairs
the biosynthesis of cmnm
5U, the nucleoside normally present
in the wobble position of mitochondrial tRNA
Lys (32), which
strongly supports the idea that the function of GidA is
evolutionarily conserved. Similarly, disruption of MSS1, the
homologous gene of mnmE in yeast, also impairs biosynthesis
of cmnm
5U (32), which argue in favour of a conservative
evolution of the cmnm
5U biosynthesis pathway. However,
the precise role of MnmE and GidA family proteins in this
pathway remains undetermined. One way to gain insights
into such a role is by elucidating the activities of both
 
 
 
 
 
 
 
 
 
Figure 8. Western blot analysis of total extracts from strains MG1655
(wild-type) and IC5241 (gidA::Tn10) transformed with pJF119 or its
derivatives pIC1154, pIC1177, pIC1178 and pIC1179 (carrying the
wild-type, G13A, G15A and G13A/G15A gidA alleles, respectively), using
anti-GidA antibody. The strains were grown during 2.5 h in LBT at 37 C with
or without 1 mM IPTG, before processed. 50 mg of total proteins were loaded
in each well. Size of the molecular weight marker (on the left) is in kDa.
Table 2. Levels of s
2U in mutant strains
Strain
a Relevant genotype s
2U/s
4U
b
Chromosome Plasmid
MG1655 mnmE::kan — 0.026
MG1655 gidA::Tn10 — 0.022
MG1655 ( ) gidA::Tn10 GidA G13A 0.011
MG1655 ( ) gidA::Tn10 GidA G15A 0.016
MG1655 ( ) gidA::Tn10 GidA G13AG15A 0.025
MG1655 (+) gidA::Tn10 GidA G13A 0.004
MG1655 (+) gidA::Tn10 GidA G15A 0.006
MG1655 (+) gidA::Tn10 GidA G13AG15A 0.026
a(+) and ( ) indicate presence or absence of inducer IPTG in the growth
medium.
bThe numbers are calculated as the absorbance of s
2U relative to the
absorbance of s
4U at 314 nm (values were taken from Figure 7).
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Thus, we have previously found that E.coli MnmE exhibits
a GTPase activity that is essential for that function (8,10).
Moreover, biochemical and structural data indicated that
T.maritima MnmE binds 5-formyl-tetrahydrofolate (9). This
strongly supports a direct participation of MnmE in the
tRNA modiﬁcation reaction since formyl-tetrahydrofolate
might be used as the one-carbon unit donor in the formation
of the cmnm group (Figure 1). Such a proposal is in line with
previous data indicating that the ﬁrst carbon atom in the
side chain at 5 position of cmnm
5U originates from a source
other than methionine (6). Furthermore, alignment of GidA
proteins and their paralogues TrmFO revealed a highly
conserved dinucleotide-binding motif near the N-terminus
(1,2). In fact, the TrmFO proteins from M.xanthus and
B.subtilis (1,2), and GidA proteins from B.subtilis and
E.coli (2,9) were reported to bind FAD, although in the
case of GidA proteins, data were never shown. In this respect,
we have found here that GidA contains noncovalently bound
FAD (Figure 6A), and that change to alanine of G13 and G15,
two residues belonging to the FAD-binding motif of
GidA, impairs capability of this protein to modify tRNA
(Figure 7). This indicates that GidA, whichever the mecha-
nism of U34 modiﬁcation is, catalyses an FAD-depending
reaction that is also required for generation of cmnm
5U.
Immunoelectron microscopy and subcellular fractionation
indicated that MnmE is localized in both the cytoplasm
and, to a lesser but signiﬁcant extent, the inner membrane
(7,8). In this work, experiments of subcellular fractionation
show that GidA is mostly found in the soluble fraction,
although at least a portion was also detected in the membrane
fraction (Figure 2B). We ﬁnd this to be indicative that both
proteins have identical subcellular distribution. A predomi-
nant cytoplasmic localization, or even a partial association
with the cytoplasmic membrane inner face, is foreseeable
for enzymes whose substrate is tRNA. Moreover, we show
for the ﬁrst time that puriﬁed MnmE and GidA proteins
interacts in vitro (Figure 4). Altogether, these results suggest
that both proteins form a functional complex that carries out
the modiﬁcation reaction. Considering that dimerization of
MnmE is required to form its tetrahydrofolate binding site
(9) and that GidA mostly forms dimers (Figure 3), it seems
reasonable to propose that a heterotetramer of type a2b2i s
the functional form of the MnmE GidA complex. In fact,
our results from gel ﬁltration experiments and analysis in
native gels strongly support this proposal (Figure 5). It is of
interest to mention that whilst the apparent mass of the
MnmE dimer estimated from gel ﬁltration is larger than
expected (149 versus 100 kDa), because of its elongated
shape (9), the apparent mass of the a2b2 MnmE GidA com-
plex is smaller than expected ( 195 kDa, see Figure 5A).
Since the mobility of particles on gel ﬁltration depends on
their size and their shape, our results suggest that formation
of the heterotetrameric complex increases the compactness
of the interacting partners. The MnmE GidA complex runs
in native gels with an apparent mass of about 250 kDa,
which ﬁts well with the expected mass for a heterotetramer
of type a2b2 (Figure 5C).
MnmE and GidA are evolutionarily conserved proteins
present in mitochondria of yeast and human (28–31).
Interestingly, taurine is directly incorporated into human
mitochondrial tRNAs in a modiﬁcation process that probably
involves the human MnmE and GidA homologues (32,39).
Thus, it was proposed a model where both proteins catalyse
the formation of an unknown intermediate, and the subse-
quent activity of a taurine or glycine transferase is responsible
for construction of the 5-taurinomethyl group in humans, or
5-cmnm group in yeast and bacteria [(32), see Figure 9A].
On the other hand, differences in growth rate between
E.coli mnmE and gidA null mutants led to the idea that the
MnmE activity precedes that of GidA in the tRNA modiﬁca-
tion pathway (4). Thus, considering the ability of MnmE and
GidA to bind 5-formyl-tetrahydrofolate and FAD, respec-
tively, it was proposed a new model where MnmE catalyses
the transfer of the formyl group from formyl-tetrahydrofolate
onto the 5 position of the uridine base, producing a formylated
Figure 9. Models for the biosynthetic pathway leading to cmnm
5U34, summarized from references 32 (A) and 9 (B).
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and catalyses a reduction reaction required for generation of
the cmnm
5 modiﬁcation [(9), see Figure 9B]. According to
this model, in the HPLC analysis from tRNA hydrolysates,
we would expect to observe disappearance of s
2Ui fa
thiolated intermediate (s
2f
5U) were synthesized by MnmE
in gidA mutants. In contrast, s
2U is present in hydrolysates
of tRNA isolated from mutants gidA::Tn10 and G13A/
G15A (Figure 7). In fact, the relative levels of s
2U found in
these mutants were near identical to those found in the
mnmE::kan strain (Table 2). We have observed that MnmE
is pulled down by the FLAG-GidA G13A/G15A mutant
protein (data not shown), which indicates that the FAD-
binding ability of GidA is not required for the physical
interaction with MnmE. However, MnmE does not seem to
work successfully in the presence of protein G13A/G15A
since s
2U, as pointed out above, is found in tRNA of
mutant G13A/G15A at similar levels than in tRNA from
the mnmE::kan mutant (Figure 7 and Table 2). These results
do not support previous proposals that activity of MnmE
precedes that of GidA in the MnmE/GidA pathway (4,9);
rather, our data ﬁt better with a model where proteins GidA
and MnmE form a functional complex in which both
proteins are interdependent. Moreover, we have not observed
differences between the growth rate of gidA and mnmE
mutants in minimal medium, so that we think that differences
reported by other authors (4) might be due to polar effects of
the gidA::Tn10 mutation used in their experiments. The
similar phenotype produced by loss-of-function gidA and
mnmE mutations on cell survival and cell growth that we
describe here (see subsection ‘Phenotype of GidA mutants’)
also supports a model in which MnmE and GidA are interde-
pendent proteins. Development of an in vitro assay using
a recombinant MnmE GidA complex will provide a key
to clarify the molecular mechanism of the MnmE/GidA
dependent pathway.
Phylogenetic analysis indicate that GidA and TrmFO
protein families have evolved from a common ancestor but
acquired different, non-overlapping cellular functions during
evolution (2). Our results clearly show that GidA and
MnmE form a heterocomplex, and suggest that both proteins
drive the tRNA modiﬁcation process by forming such a
complex. In other words, whilst the TrmFO enzymes catalyze
folate-dependent formation of 5-methyluridine at position
54 of tRNA by themselves (2), GidA requires association
with MnmE to catalyze formation of cmnm
5U at position
34. Thus, the MnmE GidA complex seems to represent a
new evolutionary way to use a folate derivative and FAD
in the post-transcriptional modiﬁcation of tRNA.
Interestingly, s
2mnm
5U was reported to be present in tRNA
from Archaea (40). However, we have not found homologous
of gidA and mnmE in the sequenced genomes of archaeal
organisms. Search for mnmE homologues led to ﬁnd proteins
from Archaea that only exhibit a minor homology with
MnmE in the G domain, which could just indicate that they
are GTP-binding proteins. Thus, it seems that if ancient
gidA and mnmE homologues there existed, divergent evolu-
tion between Bacteria and Archaea has produced proteins
with a very low level of homology, even undetectable in
the case of GidA. Alternatively, it might be possible that
formation of mnm
5 in Archaea depends on proteins that are
not evolutionarily related to MnmE and GidA. If so, this
would mean that a pathway for synthesis of mnm
5 has been
established independently at least twice during evolution.
ACKNOWLEDGEMENTS
The authors thank Dr E. Knecht, Dr M. J. Vicent-Doco ´n, and
Dr J. F. Sanz-Cervera for valuable advice, Dr D. Bre ´geon for
the generous gift of strains, and Dr M. Vicente for the
anti-EF-Tu antibody. The authors also thank Silvia Prado and
Rafa Ruiz for donating purified rMnmE and FLAG-GidA
proteins used in some experiments, Magda Villarroya and
Elvira Cebolla for allowing us to use their data on growth
rate of mutants mnmE and gidA, and Rafa Ruiz and Alfonso
Benı ´tez for discussions during preparation of this manuscript.
I.M. is a Fellow of Bancaixa and Centro de Investigacio ´n
Prı ´ncipe Felipe. This work was supported in part by the
Ministerio de Educacio ´n y Ciencia (Grants BMC2001-1555
and BFU2004-05819), the Ministerio de Sanidad (Grants
G03/203, G03/011, and PI051791) and the Generalidad
Valenciana (Grant GRUPOS04/07) to M.-E.A., and by grants
from the Swedish Cancer Foundation (Project 680) and the
Swedish Science Research Council (Project BU-2930) to
G.R.B. Funding to pay the Open Access publication charges
for this article was provided by the Ministerio de Educacio ´ny
Ciencia (Grant BFU2004-05819).
Conflict of interest statement. None declared.
REFERENCES
1. White,D.J., Merod,R., Thomasson,B. and Hartzell,P.L. (2001) GidA
is an FAD-binding protein involved in development of Myxococcus
xanthus. Mol. Microbiol., 42, 503–517.
2. Urbonavic ˇius,J., Skouloubris,S., Myllykallio,H. and Grosjean,H. (2005)
Identification of a novel gene encoding a flavin-dependent tRNA:m5U
methyltransferase in bacteria-evolutionary implications. Nucleic Acids
Res., 33, 3955–3964.
3. von Meyenburg,K., Jørgensen,B.B., Nielsen,J. and Hansen,F.G. (1982)
Promoters of the atp operon coding for the membrane-bound ATP
synthase of Escherichia coli mapped by Tn10 insertion mutations.
Mol. Gen. Genet., 188, 240–248.
4. Bre ´geon,D., Colot,V., Radman,M. and Taddei,F. (2001) Translational
misreading: a tRNA modification counteracts a +2 ribosomal
frameshift. Genes Dev., 15, 2295–2306.
5. Elseviers,D., Petrullo,L.A. and Gallagher,P. (1984) Novel E. coli
mutants deficient in biosynthesis of
5-methylaminomethyl-2-thiouridine. Nucleic Acids Res., 12,
3521–3534.
6. Hagervall,T.G., Edmonds,C.G., McCloskey,J.A. and Bjo ¨rk,G.R. (1987)
Transfer RNA(5-methylaminomethyl-2-thiouridine)-methyltransferase
from Escherichia coli K-12 has two enzymatic activities. J. Biol.
Chem., 262, 8488–8495.
7. Cabedo,H., Macia ´n,F., Villarroya,M., Escudero,J.C.,
Martı ´nez-Vicente,M., Knecht,E. and Armengod,M.E. (1999)
The Escherichia coli trmE (mnmE) gene, involved in tRNA
modification, codes for an evolutionarily conserved GTPase with
unusual biochemical properties. EMBO J., 18, 7063–7076.
8. Yim,L., Martı ´nez-Vicente,M., Villarroya,M., Aguado,C., Knecht,E.
and Armengod,M.E. (2003) The GTPase activity and C-terminal
cysteine of the Escherichia coli MnmE protein are essential for its
tRNA modifying function. J. Biol. Chem., 278, 28378–28387.
9. Scrima,A., Vetter,I.R., Armengod,M.E. and Wittinghofer,A. (2005)
The structure of the TrmE GTP-binding protein and its implications for
tRNA modification. EMBO J., 24, 23–33.
5904 Nucleic Acids Research, 2006, Vol. 34, No. 2010. Martı ´nez-Vicente,M., Yim,L., Villarroya,M., Mellado,M.,
Pe ´rez-Paya ´,E., Bjo ¨rk,G.R. and Armengod,M.E. (2005) Effects of
mutagenesis in the switch I region and conserved arginines of
Escherichia coli MnmE protein, a GTPase involved in tRNA
modification. J. Biol. Chem., 280, 30660–30670.
11. Kambampati,R. and Lauhon,C.T. (2003) MnmA and IscS are required
for in vitro 2-thiouridine biosynthesis in Escherichia coli.
Biochemistry, 42, 1109–1117.
12. Bujnicki,J.M., Oudjama,Y., Roovers,M., Owczarek,S., Caillet,J. and
Droogmans,L. (2004) Identification of a bifunctional enzyme MnmC
involved in the biosynthesis of a hypermodified uridine in the wobble
position of tRNA. RNA, 10, 1236–1242.
13. Ikeuchi,I., Shigi,N., Kato,J., Nishimura,A. and Suzuki,T. (2006)
Mechanistic insights into sulfur relay by multiple sulfur mediators
involved in thiouridine biosynthesis at tRNA wobble positions.
Mol. Cell, 21, 97–108.
14. Wolfe,M.D., Ahmed,F., Lacourciere,G.M., Lauhon,C.T.,
Stadtman,T.C. and Larson,T.J. (2004) Functional diversity of the
rhodanese homology domain: the Escherichia coli ybbB gene encodes
a selenophosphate-dependent tRNA 2-selenouridine synthase. J. Biol.
Chem., 279, 1801–1809.
15. Chen,P., Crain,P.F., Na ¨svall,S.J., Pomerantz,S.C. and Bjo ¨rk,G.R.
(2005) A ‘gain of function’ mutation in a protein mediates production
of novel modified nucleosides. EMBO J., 24, 1842–1851.
16. Bjo ¨rk,G.R. and Hagervall,T.G. (2005) Transfer tRNA modification.
In Curtiss,R., III, Bo ¨ck,A., Ingrahan,J.L., Kaper,J.B., Maloy,S.,
Neidhardt,F.C., Riley,M.M., Squires,C.L. and Wanner,B.L. (eds),
Escherichia coli and Salmonella: Cellular and Molecular Biology.
[Online] http://www.ecosal.org. ASM Press, Washington DC.
17. Kru ¨ger,M.K. and Sørensen,M.A. (1998) Aminoacylation of
hypomodified tRNAGlu in vivo. J. Mol. Biol., 284, 609–620.
18. Curran,J.M. (1998) Modified nucleosides in translation. In Grosjean,H.
and Benne,R. (eds), Modification and Editing of RNA. American
Society for Microbiology, Washington, D.C., pp. 493–516.
19. Urbonavic ˇius,J., Quian,Q., Durand,J.M.B., Hagervall,T.G. and
Bjo ¨rk,G.R. (2001) Improvement of reading frame maintenance is
a common function for several tRNA modifications. EMBO J., 20,
4863–4873.
20. Yarian,C., Townsend,H., Czestkowski,W., Sochacka,E.,
Malkiewicz,A.J., Guenther,R., Miskiewicz,A. and Agris,P.F. (2002)
Accurate translation of the genetic code depends on tRNA modified
nucleosides. J. Biol. Chem., 277, 16391–16395.
21. Kinscherf,T.G. and Willis,D.K. (2002) Global regulation by gidA in
Pseudomonas syringae. J. Bacteriol., 184, 2281–2286.
22. Sha,J., Kozlova,E.V., Fadl,A.A., Olano,J.P., Houston,C.W.,
Peterson,J.W. and Chopra,A.K. (2004) Molecular characterization of
a glucose-inhibited division gene, gidA, that regulates cytotoxic
enterotoxin of Aeromonas hydrophila. Infect. Immun., 72, 1084–1095.
23. Alam,K.Y. and Clark,D.P. (1991) Molecular cloning and sequence of
the thdF gene, which is involved in thiophene and furan oxidation by
Escherichia coli. J. Bacteriol., 173, 6018–6024.
24. Gong,S., Ma,Z. and Foster,J.W. (2004) The Era-like GTPase TrmE
conditionally activates gadE and glutamate-dependent acid resistance
in Escherichia coli. Mol. Microbiol., 54, 948–961.
25. Nakayashiki,T. and Inokuchi,H. (1998) Novel temperature-sensitive
mutants of Escherichia coli that are unable to grow in the absence of
wild-type tRNA6
Leu. J. Bacteriol., 180, 2931–2935.
26. Forsyth,R.A., Haselbeck,R.J., Ohlsen,K.L., Yamamoto,R.T., Xu,H.,
Trawick,J.D., Wall,D., Wang,L., Brown-Driver,V., Froelich,J.M. et al.
(2002) A genome-wide strategy for the identification of essential genes
in Staphylococcus aureus. Mol. Microbiol., 43, 1387–1400.
27. Karita,M., Etterbeek,M.L., Forsyth,M.H., Tummuru,M.K.R. and
Blaser,M.J. (1997) Characterization of Helicobacter pylori dapE and
construction of a conditionally lethal dapE mutant. Infect. Immun., 65,
4158–4164.
28. Decoster,E., Vassal,A. and Faye,G. (1993) MSS1, a nuclear-encoded
mitochondrial GTPase involved in the expression of COX1 subunit of
cytochrome c oxidase. J. Mol. Biol., 232, 79–88.
29. Colby,G., Wu,M. and Tzagoloff,A. (1998) MTO1 codes for a
mitochondrial protein required for respiration in paromomycin-resistant
mutants of Saccharomyces cerevisiae. J. Biol. Chem., 273,
27945–27952.
30. Li,X. and Guan,M.-X. (2002) A human mitochondrial GTP binding
protein related to tRNA modification may modulate phenotypic
expression of the deafness-associated mitochondrial 12S rRNA
mutation. Mol. Cell. Biol., 22, 7701–7711.
31. Li,X., Li,R., Lin,X. and Guan,M.X. (2002) Isolation and
characterization of the putative nuclear modifier gene MTO1 involved
in the pathogenesis of deafness-associated mitochondrial 12 S rRNA
A1555G mutation. J. Biol. Chem., 277, 27256–27264.
32. Umeda,N., Suzuki,T., Yukawa,M., Ohya,Y., Shindo,H., Watanabe,K.
and Suzuki,T. (2005) Mitochondria-specific RNA-modifying enzymes
responsible for the biosynthesis of the wobble base in mitochondrial
tRNAs. Implications for the molecular pathogenesis of human
mitochondrial diseases. J. Biol. Chem., 280, 1613–1624.
33. Miller,J.H. (1992) A Short Course in Bacterial Genetics. Cold Spring
Harbor Laboratory Press, Cold Spring Harbor, NY.
34. Ujita,S. and Kimura,K. (1982) Glucose-6-phosphate dehydrogenase,
vegetative and spore Bacillus subtilis. Meth. Enzymol., 89, 258–261.
35. Light,D.R., Walsh,C. and Marletta,M.A. (1980) Analytical and
preparative high-performance liquid chromatography separation
of flavin and flavin analog coenzymes. Anal. Biochem., 109, 87–93.
36. Dym,O. and Eisenberg,D. (2001) Sequence-structure analysis of
FAD-containing proteins. Protein Sci., 10, 1712–1728.
37. Yokoyama,S. and Nishimura,S. (1995) Modified nucleosides and
codon recognition. In So ¨ll,D. and RajBhandary,U.L. (eds), tRNA:
Structure, Biosynthesis, and Function. ASM Press, Washington, D.C.,
pp. 207–223.
38. Agris,P.F. (2004) Decoding the genome: a modified view. Nucleic
Acids Res., 32, 223–238.
39. Suzuki,T., Suzuki,T., Wada,T., Saigo,K. and Watanabe,K. (2002)
Taurine as a constituent of mitochondrial tRNAs: new insights into the
functions of taurine and human mitochondrial diseases. EMBO J., 21,
6581–6589.
40. McCloskey,J.A., Graham,D.E., Zhou,S., Crain,P.F., Ibba,M.,
Konisky,J., So ¨ll,D. and Olsen,G.J. (2001) Post-transcriptional
modification in archaeal tRNAs: identities and phylogenetic
relations of nucleotides from mesophilic and hyperthermophilic
Methanococcales. Nucleic Acids Res., 29, 4699–4706.
41. Gehrke,C.W. and Kuo,K.C. (1989) Ribonucleoside analysis
by reversed-phase high-performance liquid chromatography.
J. Chromatogr., 471, 3–36.
42. Hanahan,D. (1983) Studies on transformation of Escherichia coli with
plasmids. J. Mol. Biol., 166, 557–580.
43. Bachmann,B. (1996) Derivations and genotypes of some mutant
derivatives of Escherichia coli K-12. In Neidhardt,F.C. et al. (ed.),
Escherichia coli and Salmonella: Cellular and Molecular Biology.
American Society for Microbiology, Washington, D.C.,
pp. 2460–2488.
44. Guzma ´n,L.M., Belin,D., Carson,M.J. and Beckwith,J. (1995) Tight
regulation, modulation, and high-level expression by vectors containing
the arabinose PBAD promoter. J. Bacteriol., 177, 4121–4130.
45. Goloubinoff,P., Gatenby,A.A. and Lorimer,G.H. (1989) GroE
heat-shock proteins promote assembly of foreign prokaryotic ribulose
bisphosphate carboxylase oligomers in Escherichia coli. Nature, 337,
44–47.
46. Furste,J.P., Pansegrau,W., Frank,R., Blocker,H., Scholz,P.,
Bagdasarian,M. and Lanka,E. (1986) Molecular cloning of the plasmid
RP4 primase region in a multi-host-range tacP expression vector.
Gene, 48, 119–131.
Nucleic Acids Research, 2006, Vol. 34, No. 20 5905